Lung Neoplasms: all 7,334 studies
Page 8 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by BrigatinibRecruitingNCT06620835Phase 2
- Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical TrialNot yet recruitingNCT06620822Phase 2
- Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane BlockRecruitingNCT06618599Not applicable
- A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsRecruitingNCT06618287Phase 1/2
- A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLCRecruitingNCT06617416Phase 3
- Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)RecruitingNCT06616584Phase 2/3
- A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung CancerNot yet recruitingNCT06614621Phase 2
- Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung CancerNot yet recruitingNCT06614231Phase 2
- Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLCNot yet recruitingNCT06613308
- 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.RecruitingNCT06608160
- Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLCNot yet recruitingNCT06607926Not applicable
- Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without ChemoimmunotherapyRecruitingNCT06607796Phase 3
- Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung CancersRecruitingNCT06607770Phase 1/2
- Leveraging the Emergency Department (LEAD) StudyRecruitingNCT06605534Not applicable
- AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain MetastasesRecruitingNCT06604689
- Microplastics in the Human Respiratory SystemNot yet recruitingNCT06603675
- Reinforced and Non-Reinforced Staple Lines in Fissureless LobectomyNot yet recruitingNCT06602661Phase 1
- The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer SurgeryNot yet recruitingNCT06600503Not applicable
- Immuno-effect of Tα1 for Stage I NSCLCRecruitingNCT06598839Not applicable
- Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective StudyRecruitingNCT06598527Phase 3
- Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLCNot yet recruitingNCT06597513Phase 1/2
- The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer PatietnsNot yet recruitingNCT06592430
- Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung CancerNot yet recruitingNCT06591910
- PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06590194Phase 1/2
- A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT06589778Phase 1/2
- The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in ChinaNot yet recruitingNCT06586801
- A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLCNot yet recruitingNCT06585644Phase 2
- Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung CancersNot yet recruitingNCT06585059Phase 1
- Quest to Analyze One Thousand Humans MeditatingEnrolling by invitationNCT06583395
- Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain MetastasisRecruitingNCT06582940Phase 2
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung CancerNot yet recruitingNCT06581380Phase 3
- Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation ProceduresNot yet recruitingNCT06581107Not applicable
- Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung CancerNot yet recruitingNCT06580665Not applicable
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Next Generation Chest X-Ray Tomosynthesis for Screening of Lung CancerRecruitingNCT06577883
- Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery PatientsRecruitingNCT06577844Not applicable
- An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UKRecruitingNCT06575439
- Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.RecruitingNCT06574347Phase 2
- Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung CancerRecruitingNCT06572540Not applicable
- Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.RecruitingNCT06563999Phase 2
- Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialRecruitingNCT06563388Phase 3
- Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung CancerRecruitingNCT06562920Phase 2
- A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06561685Phase 1
- CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLCNot yet recruitingNCT06557096Early Phase 1
- EB-OCT Biopsy Guidance of Lung CancerNot yet recruitingNCT06556680Not applicable
- Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung CancerNot yet recruitingNCT06554535Phase 2
- Analysis of Lung Cancer Tissue With Spatial Frequency Domain ImagingEnrolling by invitationNCT06549088
- Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung CancerRecruitingNCT06548711Not applicable
- Rarecells Molecular Biomarkers for Early Detection of Lung CancerRecruitingNCT06546007
- Virtual Personalized Exercise Program for Lung Cancer PatientsRecruitingNCT06540495Not applicable
- The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung CancerRecruitingNCT06540196Not applicable
- Prediction Augmented Screening InitiativeRecruitingNCT06538636Not applicable
- TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung CancerRecruitingNCT06538012Phase 1/2
- Lung Cancer Screening Program in MexicoRecruitingNCT06535451
- Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction TreatmentRecruitingNCT06534489
- Nutritional Therapy Enriched With Omega-3 in Patients With Lung ResectionRecruitingNCT06531460Not applicable
- Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and CharacterizationNot yet recruitingNCT06531343Not applicable
- A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical SurgeryNot yet recruitingNCT06530719Phase 2
- Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary NodulesNot yet recruitingNCT06530667Not applicable
- Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMERRecruitingNCT06528743Not applicable
- Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung CancerRecruitingNCT06527898Phase 1/2
- A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung CancerNot yet recruitingNCT06526624Phase 3
- A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerNot yet recruitingNCT06525350Phase 2
- Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung CancerRecruitingNCT06523673Phase 3
- Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsRecruitingNCT06523582
- Value of F-18 FDG PET/CT for the Prediction of EGFR Mutation in Lung Cancer PatientsNot yet recruitingNCT06520189
- Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled BreathRecruitingNCT06518655
- Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung CancerRecruitingNCT06518057Phase 2
- Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung CancerRecruitingNCT06514118
- Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With PollutionEnrolling by invitationNCT06512142
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid TumorsRecruitingNCT06508307Phase 1
- Biomarker Discovery in Lung Cancer - MalaysiaRecruitingNCT06504927
- Transthoracic vs Transbronchial Radiofrequency Ablation for Lung CancerRecruitingNCT06503744Not applicable
- The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer PatientsRecruitingNCT06503432
- A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLCNot yet recruitingNCT06503042
- Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialRecruitingNCT06500481Phase 3
- Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）RecruitingNCT06500312
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialRecruitingNCT06498635Phase 3
- The Application of Rapid Fresh Digital Pathology on the Diagnosis and Biomarker Testing of Lung CancerNot yet recruitingNCT06497686
- Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung CancerRecruitingNCT06496360
- Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLCRecruitingNCT06496048Phase 3
- Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung CancerRecruitingNCT06495125Phase 2
- Added Value of PET/CT in Lung CancerNot yet recruitingNCT06494800
- Post-Operative Prediction of PulmonarY FunctionRecruitingNCT06494254
- Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.RecruitingNCT06492421Phase 2
- Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized TrialRecruitingNCT06485544Phase 2
- A Study to Evaluate Guideline Adoption Through Quality Improvement Project (QIP) in Pulmonary and Critical Care Medicine (PCCM) DepartmentNot yet recruitingNCT06484972
- IMPT Dose Escalation for NSCLC (HyDose)RecruitingNCT06484491Not applicable
- Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the SurgeryRecruitingNCT06483698
- Environmental Pollutants in COPD and Lung CancerRecruitingNCT06483490
- Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via ITRecruitingNCT06483347Phase 2
- Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet PlatformRecruitingNCT06483295Not applicable
- Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLCNot yet recruitingNCT06483009Phase 4
- Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized CareRecruitingNCT06482073
- Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer PatientsRecruitingNCT06481813Not applicable
- Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical TrialRecruitingNCT06481566Not applicable
- Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung CancerRecruitingNCT06480864Not applicable
- Radiotherapy to All Residual Lesions After ChemoimmunotherapyRecruitingNCT06479473Phase 1/2
- Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung CancerRecruitingNCT06477302